nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—Irbesartan—CYP2D6—Parkinson's disease	0.00863	0.46	CrCbGaD
Valsartan—Candesartan—ABCB1—Parkinson's disease	0.00616	0.328	CrCbGaD
Valsartan—Losartan—ABCB1—Parkinson's disease	0.00397	0.212	CrCbGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00208	0.00212	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.00208	0.00212	CbGpPWpGaD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00203	0.00207	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—NDUFB11—Parkinson's disease	0.002	0.00203	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.00198	0.00202	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00198	0.00202	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00196	0.002	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00195	0.00199	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.00193	0.00196	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DGKQ—Parkinson's disease	0.00191	0.00195	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GPR37—Parkinson's disease	0.00191	0.00195	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PDYN—Parkinson's disease	0.00191	0.00194	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GCH1—Parkinson's disease	0.0019	0.00194	CbGpPWpGaD
Valsartan—ALB—Hemostasis—DGKQ—Parkinson's disease	0.00189	0.00193	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—INS—Parkinson's disease	0.00183	0.00187	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00183	0.00187	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—GRM5—Parkinson's disease	0.00177	0.00181	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00175	0.00178	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—EDN1—Parkinson's disease	0.00173	0.00176	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00172	0.00175	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00171	0.00174	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—FBP1—Parkinson's disease	0.0017	0.00173	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GBA—Parkinson's disease	0.0017	0.00173	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—DBH—Parkinson's disease	0.0017	0.00173	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—IL1B—Parkinson's disease	0.00168	0.00171	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00166	0.00169	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00164	0.00167	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00164	0.00167	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.0016	0.00163	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00157	0.0016	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RIT2—Parkinson's disease	0.00153	0.00156	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00152	0.00155	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00151	0.00154	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00151	0.00154	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ND3—Parkinson's disease	0.0015	0.00153	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MCCC1—Parkinson's disease	0.0015	0.00153	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.00149	0.00152	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00148	0.00151	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00146	0.00149	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—INS—Parkinson's disease	0.00146	0.00148	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GRK5—Parkinson's disease	0.00145	0.00148	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00144	0.00147	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.00143	0.00146	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00142	0.00145	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00142	0.00145	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—OMD—Parkinson's disease	0.00141	0.00144	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TALDO1—Parkinson's disease	0.00141	0.00144	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00141	0.00144	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.0014	0.00142	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00139	0.00142	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL1B—Parkinson's disease	0.00137	0.00139	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00135	0.00137	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NDUFB11—Parkinson's disease	0.00134	0.00137	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.00131	0.00133	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00131	0.00133	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GRM4—Parkinson's disease	0.0013	0.00133	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00129	0.00132	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—TAC1—Parkinson's disease	0.00129	0.00131	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GCH1—Parkinson's disease	0.00128	0.0013	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—DRD1—Parkinson's disease	0.00126	0.00129	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00126	0.00128	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—DDC—Parkinson's disease	0.00125	0.00127	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00124	0.00126	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PENK—Parkinson's disease	0.00123	0.00126	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MAG—Parkinson's disease	0.00123	0.00126	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—DRD3—Parkinson's disease	0.00122	0.00125	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.00122	0.00124	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—DRD2—Parkinson's disease	0.00122	0.00124	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR7—Parkinson's disease	0.00122	0.00124	CbGpPWpGaD
Valsartan—ALB—Hemostasis—MAG—Parkinson's disease	0.00122	0.00124	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.0012	0.00122	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00119	0.00121	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTA4—Parkinson's disease	0.00118	0.0012	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00116	0.00118	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00115	0.00118	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00114	0.00117	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DBH—Parkinson's disease	0.00114	0.00116	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—FBP1—Parkinson's disease	0.00114	0.00116	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GBA—Parkinson's disease	0.00114	0.00116	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PDYN—Parkinson's disease	0.00113	0.00115	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00112	0.00114	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—DRD2—Parkinson's disease	0.00111	0.00113	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR7—Parkinson's disease	0.00111	0.00113	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.00111	0.00113	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.00109	0.00111	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.00109	0.00111	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.00108	0.0011	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.00108	0.0011	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.00107	0.00109	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00107	0.00109	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GFAP—Parkinson's disease	0.00106	0.00108	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PLA2G6—Parkinson's disease	0.00106	0.00108	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.00105	0.00107	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MAOB—Parkinson's disease	0.00105	0.00107	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GRM5—Parkinson's disease	0.00105	0.00107	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000998	0.00102	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000996	0.00102	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TNF—Parkinson's disease	0.000993	0.00101	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000992	0.00101	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.000992	0.00101	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.000985	0.001	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000979	0.000997	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000976	0.000995	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000957	0.000975	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.00093	0.000948	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—FGF20—Parkinson's disease	0.000919	0.000937	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000913	0.00093	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000891	0.000908	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—EDN1—Parkinson's disease	0.000886	0.000903	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000868	0.000885	CbGpPWpGaD
Valsartan—ALB—Metabolism—MCCC1—Parkinson's disease	0.00086	0.000876	CbGpPWpGaD
Valsartan—ALB—Metabolism—ND3—Parkinson's disease	0.00086	0.000876	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000854	0.00087	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DDC—Parkinson's disease	0.000837	0.000853	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000832	0.000847	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—INSR—Parkinson's disease	0.000822	0.000838	CbGpPWpGaD
Valsartan—ALB—Metabolism—OMD—Parkinson's disease	0.000808	0.000824	CbGpPWpGaD
Valsartan—ALB—Metabolism—TALDO1—Parkinson's disease	0.000808	0.000824	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL6—Parkinson's disease	0.000801	0.000817	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000799	0.000814	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000798	0.000813	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTA4—Parkinson's disease	0.00079	0.000805	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000789	0.000804	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00078	0.000795	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CYP2D6—Parkinson's disease	0.000779	0.000794	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—FGB—Parkinson's disease	0.000777	0.000792	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000775	0.00079	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR1A—Parkinson's disease	0.000773	0.000788	CbGpPWpGaD
Valsartan—ALB—Hemostasis—FGB—Parkinson's disease	0.000768	0.000783	CbGpPWpGaD
Valsartan—ALB—Metabolism—NDUFB11—Parkinson's disease	0.000766	0.000781	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CTGF—Parkinson's disease	0.000765	0.00078	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TAC1—Parkinson's disease	0.000761	0.000776	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000747	0.000762	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD1—Parkinson's disease	0.000747	0.000761	CbGpPWpGaD
Valsartan—ALB—Metabolism—GCH1—Parkinson's disease	0.000731	0.000745	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD3—Parkinson's disease	0.000723	0.000737	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CYP2E1—Parkinson's disease	0.000713	0.000726	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PLA2G6—Parkinson's disease	0.000712	0.000725	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—NQO1—Parkinson's disease	0.000705	0.000718	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MAOB—Parkinson's disease	0.000704	0.000718	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ND3—Parkinson's disease	0.000704	0.000717	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.000704	0.000717	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—TH—Parkinson's disease	0.000695	0.000708	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000675	0.000688	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00067	0.000683	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CYCS—Parkinson's disease	0.000667	0.00068	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—OMD—Parkinson's disease	0.000662	0.000674	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.000662	0.000674	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000659	0.000672	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR7—Parkinson's disease	0.000654	0.000667	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD2—Parkinson's disease	0.000654	0.000667	CbGpPWpGaD
Valsartan—ALB—Metabolism—FBP1—Parkinson's disease	0.000651	0.000664	CbGpPWpGaD
Valsartan—ALB—Metabolism—GBA—Parkinson's disease	0.000651	0.000664	CbGpPWpGaD
Valsartan—ALB—Metabolism—DBH—Parkinson's disease	0.000651	0.000664	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000637	0.000649	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000627	0.000639	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.000598	0.00061	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—COMT—Parkinson's disease	0.000591	0.000602	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTP1—Parkinson's disease	0.000588	0.000599	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MAOA—Parkinson's disease	0.000586	0.000598	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—HMOX1—Parkinson's disease	0.00058	0.000591	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SOD1—Parkinson's disease	0.00057	0.000581	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000569	0.00058	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ABCB1—Parkinson's disease	0.000556	0.000567	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IGF2—Parkinson's disease	0.000548	0.000559	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000547	0.000557	CbGpPWpGaD
Valsartan—ALB—Hemostasis—ABL1—Parkinson's disease	0.000544	0.000554	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IGF2—Parkinson's disease	0.000542	0.000552	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTM1—Parkinson's disease	0.00054	0.00055	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00054	0.00055	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000533	0.000543	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000533	0.000543	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000533	0.000543	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IGF1R—Parkinson's disease	0.00053	0.00054	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EDN1—Parkinson's disease	0.000524	0.000534	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP2D6—Parkinson's disease	0.000524	0.000534	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GPX1—Parkinson's disease	0.000517	0.000527	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CTGF—Parkinson's disease	0.000514	0.000524	CbGpPWpGaD
Valsartan—ALB—Hemostasis—HGF—Parkinson's disease	0.000511	0.000521	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NGF—Parkinson's disease	0.000481	0.00049	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP2E1—Parkinson's disease	0.000479	0.000488	CbGpPWpGaD
Valsartan—ALB—Metabolism—DDC—Parkinson's disease	0.000478	0.000487	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MTHFR—Parkinson's disease	0.000477	0.000486	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000475	0.000484	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NQO1—Parkinson's disease	0.000473	0.000483	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TH—Parkinson's disease	0.000467	0.000476	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR2A—Parkinson's disease	0.000458	0.000467	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000456	0.000465	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTA4—Parkinson's disease	0.000452	0.00046	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYCS—Parkinson's disease	0.000448	0.000457	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000446	0.000454	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—APOE—Parkinson's disease	0.000444	0.000453	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APOE—Parkinson's disease	0.000426	0.000434	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLA2G6—Parkinson's disease	0.000407	0.000414	CbGpPWpGaD
Valsartan—ALB—Metabolism—MAOB—Parkinson's disease	0.000402	0.00041	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—COMT—Parkinson's disease	0.000397	0.000404	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTP1—Parkinson's disease	0.000395	0.000402	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MAOA—Parkinson's disease	0.000394	0.000402	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DDC—Parkinson's disease	0.000391	0.000399	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—HMOX1—Parkinson's disease	0.000389	0.000397	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000383	0.00039	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—INS—Parkinson's disease	0.00038	0.000387	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ABCB1—Parkinson's disease	0.000374	0.000381	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.00037	0.000377	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000365	0.000372	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—INS—Parkinson's disease	0.000364	0.000371	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTM1—Parkinson's disease	0.000363	0.00037	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GPX1—Parkinson's disease	0.000348	0.000354	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.000333	0.000339	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000329	0.000336	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MTHFR—Parkinson's disease	0.000321	0.000327	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000314	0.00032	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP2D6—Parkinson's disease	0.000299	0.000305	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOE—Parkinson's disease	0.000299	0.000304	CbGpPWpGaD
Valsartan—ALB—Metabolism—CTGF—Parkinson's disease	0.000294	0.000299	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP2E1—Parkinson's disease	0.000274	0.000279	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CASP3—Parkinson's disease	0.000271	0.000276	CbGpPWpGaD
Valsartan—ALB—Metabolism—NQO1—Parkinson's disease	0.000271	0.000276	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6—Parkinson's disease	0.000269	0.000274	CbGpPWpGaD
Valsartan—ALB—Metabolism—TH—Parkinson's disease	0.000267	0.000272	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYCS—Parkinson's disease	0.000256	0.000261	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—INS—Parkinson's disease	0.000255	0.00026	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MAPK8—Parkinson's disease	0.000249	0.000254	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	0.000245	0.00025	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CTGF—Parkinson's disease	0.00024	0.000245	CbGpPWpGaD
Valsartan—ALB—Metabolism—COMT—Parkinson's disease	0.000227	0.000231	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTP1—Parkinson's disease	0.000226	0.00023	CbGpPWpGaD
Valsartan—ALB—Metabolism—MAOA—Parkinson's disease	0.000225	0.000229	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	0.000224	0.000228	CbGpPWpGaD
Valsartan—ALB—Metabolism—HMOX1—Parkinson's disease	0.000223	0.000227	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NQO1—Parkinson's disease	0.000221	0.000226	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TH—Parkinson's disease	0.000218	0.000222	CbGpPWpGaD
Valsartan—ALB—Metabolism—ABCB1—Parkinson's disease	0.000214	0.000218	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYCS—Parkinson's disease	0.00021	0.000214	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTM1—Parkinson's disease	0.000207	0.000211	CbGpPWpGaD
Valsartan—ALB—Metabolism—GPX1—Parkinson's disease	0.000199	0.000202	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—COMT—Parkinson's disease	0.000186	0.000189	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTP1—Parkinson's disease	0.000185	0.000188	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MAOA—Parkinson's disease	0.000184	0.000188	CbGpPWpGaD
Valsartan—ALB—Metabolism—MTHFR—Parkinson's disease	0.000183	0.000187	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HMOX1—Parkinson's disease	0.000182	0.000186	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ABCB1—Parkinson's disease	0.000175	0.000178	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOE—Parkinson's disease	0.000171	0.000174	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTM1—Parkinson's disease	0.00017	0.000173	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GPX1—Parkinson's disease	0.000163	0.000166	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6—Parkinson's disease	0.000159	0.000162	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MTHFR—Parkinson's disease	0.00015	0.000153	CbGpPWpGaD
Valsartan—ALB—Metabolism—INS—Parkinson's disease	0.000146	0.000149	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOE—Parkinson's disease	0.00014	0.000142	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—INS—Parkinson's disease	0.000119	0.000122	CbGpPWpGaD
